AtriCure (ATRC) Misses Q1 EPS by 4c

AtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.31), $0.04 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $47 million versus the consensus estimate of $45.46 million.

GUIDANCE:

AtriCure sees FY2018 revenue of $190-196 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c